CAN-FITE BIOPHARMA LTD's ticker is CANF and the CUSIP is 13471N102. A total of 9 filers reported holding CAN-FITE BIOPHARMA LTD in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $100,000 | -13.0% | 41,837 | -4.6% | 0.01% | -27.3% |
| Q3 2016 | $115,000 | -0.9% | 43,832 | -3.6% | 0.01% | -31.2% |
| Q2 2016 | $116,000 | +9.4% | 45,489 | +19.4% | 0.02% | +14.3% |
| Q1 2016 | $106,000 | -6.2% | 38,100 | -1.8% | 0.01% | 0.0% |
| Q4 2015 | $113,000 | +121.6% | 38,800 | +218.0% | 0.01% | +75.0% |
| Q3 2015 | $51,000 | +88.9% | 12,200 | 0.0% | 0.01% | +100.0% |
| Q2 2015 | $27,000 | 0.0% | 12,200 | 0.0% | 0.00% | +33.3% |
| Q1 2015 | $27,000 | – | 12,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TAYLOR ASSET MANAGEMENT INC | 348,500 | $763,000 | 0.14% |
| MENTA CAPITAL LLC | 12,200 | $27,000 | 0.00% |
| Virtu KCG Holdings LLC | 22,042 | $48,000 | 0.00% |
| MSI Financial Services Inc | 2,000 | $4,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 458 | $1,000 | 0.00% |
| UBS Group AG | 5,194 | $11,000 | 0.00% |
| CITIGROUP INC | 17 | $0 | 0.00% |